Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

164
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
164
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

752
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
752
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

816
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
816
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

164
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
164
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

180
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
180

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Informing Inclusive Engagement in Clinical Research: Insights From a Long-Standing Community-Based Wellness and Prescription Produce Program.

Clinical and translational science·2025
Same author

Disparities Experienced by Racial Minorities Contribute to Treatment Gaps and Lack of Access to Resources and Supports for Substance Use Disorders.

Innovation in aging·2025
Same author

Community Input for Addressing Dementia Health Disparities: Richmond Brain Health Initiative.

Progress in community health partnerships : research, education, and action·2025
Same author

Comparing four methods for assessing interprofessional learning in a practice setting.

Journal of interprofessional care·2025
Same author

A Prescription Produce Program integrating lifestyle behavior counseling and health education: A program description and evaluation.

Translational behavioral medicine·2024
Same author

Using a Device-Free Wi-Fi Sensing System to Assess Daily Activities and Mobility in Low-Income Older Adults: Protocol for a Feasibility Study.

JMIR research protocols·2024

Related Experiment Video

Updated: Dec 24, 2025

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
05:04

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training

Published on: August 9, 2024

1.4K

Geriatric Opioid Harm Reduction: Interprofessional Student Learning Outcomes.

Faika Zanjani1, Marshall Brooks1, Leland Waters1

  • 1Virginia Commonwealth University, Richmond, USA.

Gerontology & Geriatric Medicine
|April 15, 2020
PubMed
Summary

This training improved knowledge of opioid harm reduction among older adults. Key findings show increased recognition of opioids and overdose risk factors after the program.

Keywords:
agingolder adultsopioid harm reductionoverdose risk

More Related Videos

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

4.6K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.7K

Related Experiment Videos

Last Updated: Dec 24, 2025

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
05:04

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training

Published on: August 9, 2024

1.4K
Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

4.6K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.7K

Area of Science:

  • Geriatrics
  • Public Health
  • Pharmacology

Background:

  • Older adults face higher risks of negative opioid-related outcomes due to pain, multiple health conditions, and polypharmacy.
  • Opioid harm reduction strategies are crucial for this demographic.
  • Existing care models require enhanced training for effective opioid harm reduction.

Purpose of the Study:

  • To develop, implement, and evaluate an interprofessional opioid harm reduction service training tailored for older adults.
  • To assess the impact of this training on healthcare professionals' knowledge and practice.
  • To integrate harm reduction principles into community-based wellness programs.

Main Methods:

  • The study involved an interprofessional opioid harm reduction training delivered online and in-person.
  • Training was conducted within the Richmond Health and Wellness Program (RHWP), serving low-income and disabled older adults.
  • Knowledge was assessed using pre/post surveys, with follow-up case discussions and practice.

Main Results:

  • Post-training assessments showed significant increases in knowledge regarding opioid identification and overdose risk.
  • Recognition of tramadol as an opioid increased from 50% to 60%.
  • Understanding of morphine milligram equivalent (MME) and its association with overdose risk improved substantially.

Conclusions:

  • Geriatric opioid harm reduction training is feasible within community-based wellness care coordination settings.
  • The training demonstrated a positive impact on participants' knowledge.
  • Further research should investigate the impact on clinical practice and resident health outcomes.